Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bennett

Showing results (331-340 of 1,097) with videos related to

Pageof 110
Sort By:
Trends in Molecular Medicine|April 4, 2018
A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent DegradationRyan P Bennett, Jason D Salter, Harold C Smith
Neurology|September 26, 1997
Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study GroupK M Shannon, J P Bennett, J H Friedman
Biochemical Pharmacology|August 8, 2016
Pharmacological properties of microneurotrophin drugs developed for treatment of amyotrophic lateral sclerosisJames P Bennett, Laura C O'Brien, David G Brohawn
Biophysical Journal|April 1, 1986
Adrenergic modulation of the delayed rectifier potassium channel in calf cardiac Purkinje fibersP Bennett, L McKinney, T Begenisich, et al.
Neurobiology of Disease|September 3, 2005
Brain-derived growth factor and glial cell line-derived growth factor use distinct intracellular signaling pathways to protect PD cybrids from H2O2-induced neuronal deathIsaac G Onyango, Jeremy B Tuttle, James P Bennett
Biochemical and Biophysical Research Communications|October 31, 1991
Isolation and characterization of corticostatic peptides from guinea pig bone marrowJ Hu, H P Bennett, C Lazure, et al.
European Journal of Biochemistry|October 3, 1983
Detergent solubilisation of the rabbit neutrophil receptor for chemotactic formyl peptidesJ M Baldwin, J P Bennett, B D Gomperts
Neurology|August 1, 1993
Suppression of dyskinesias in advanced Parkinson's disease. II. Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptomsJ P Bennett, E R Landow, L A Schuh
American Journal of Medical Genetics|May 8, 1999
Duplication involving band 4q32 with minimal clinical effectE L Maltby, I C Barnes, C P Bennett
Vox Sanguinis|January 13, 2001
Characterization of the histo-blood group O(2) gene and its protein productM Amado, E P Bennett, F Carneiro, et al.
Pageof 110

Showing results (331-340 of 1,097) with videos related to

Sort By:
Pageof 110
Trends in Molecular Medicine|April 4, 2018
A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent DegradationRyan P Bennett, Jason D Salter, Harold C Smith
Neurology|September 26, 1997
Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study GroupK M Shannon, J P Bennett, J H Friedman
Biochemical Pharmacology|August 8, 2016
Pharmacological properties of microneurotrophin drugs developed for treatment of amyotrophic lateral sclerosisJames P Bennett, Laura C O'Brien, David G Brohawn
Biophysical Journal|April 1, 1986
Adrenergic modulation of the delayed rectifier potassium channel in calf cardiac Purkinje fibersP Bennett, L McKinney, T Begenisich, et al.
Neurobiology of Disease|September 3, 2005
Brain-derived growth factor and glial cell line-derived growth factor use distinct intracellular signaling pathways to protect PD cybrids from H2O2-induced neuronal deathIsaac G Onyango, Jeremy B Tuttle, James P Bennett
Biochemical and Biophysical Research Communications|October 31, 1991
Isolation and characterization of corticostatic peptides from guinea pig bone marrowJ Hu, H P Bennett, C Lazure, et al.
European Journal of Biochemistry|October 3, 1983
Detergent solubilisation of the rabbit neutrophil receptor for chemotactic formyl peptidesJ M Baldwin, J P Bennett, B D Gomperts
Neurology|August 1, 1993
Suppression of dyskinesias in advanced Parkinson's disease. II. Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptomsJ P Bennett, E R Landow, L A Schuh
American Journal of Medical Genetics|May 8, 1999
Duplication involving band 4q32 with minimal clinical effectE L Maltby, I C Barnes, C P Bennett
Vox Sanguinis|January 13, 2001
Characterization of the histo-blood group O(2) gene and its protein productM Amado, E P Bennett, F Carneiro, et al.
Pageof 110